Overview
- Pakistan and the WHO are implementing the Global Platform for Access to Childhood Cancer Medicines to supply quality-assured drugs at no cost.
- UNICEF will oversee procurement and delivery of the medicines, according to local reporting.
- Seven additional Pakistani centers are slated to be ready for supplies in 2027 after an expert assessment mission from January 30 to February 6, 2026.
- Pakistan reports more than 8,000 new pediatric cancer cases annually, with survival around 30% compared with about 80% in high‑income countries.
- The platform, co-founded by WHO and St. Jude in 2021, follows Pakistan’s July 29, 2025 enrollment as the second participant in the WHO Eastern Mediterranean Region.